Brief: Sionna Therapeutics Phase 1 Topline Data For Nbd1 Stabilizers Sion-719 & Sion-451 Expected This Quarter
12/05/2025 12:34
May 12 (Reuters) - Sionna Therapeutics Inc SION.O: SIONNA THERAPEUTICS: PHASE 1 TOPLINE DATA FOR NBD1 STABILIZERS SION-719 & SION-451 EXPECTED THIS QUARTER Source text: ID:nGNXcg4HLj Further company coverage: SION.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sionna Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial
Sionna hits record low after experimental drug misses mid-stage trial goal
Vertex Pharma rises after rival genetic disorder drug setback